1. Annual report 2024
  2. Research
  3. EPIVAC

EPIVAC

EPIVAC (Epidemiology and Vaccines)

The EPIVAC Group (Epidemiology and Vaccines), accredited as a consolidated research group in the SGR 2013 call and reaccredited SGR 2017, carries out epidemiological and clinical research on infectious diseases of the respiratory system preventable by vaccination, especially cohort studies evaluating the effectiveness in the practice of pneumococcal and influenza vaccinations from Primary Care. During 2017-2022 the group has carried out 3 research projects funded in competitive public calls (ISCIII and PERIS).

The members of the group have supervised 2 doctoral theses and have published (as first authors) more than 15 scientific articles in national and international biomedical journals, with a bibliometric impact factor of more than 30 points. Some of the group's work has been incorporated into the most recent updates of Cochrane reviews on the subject and has been used to establish recommendations in various clinical practice guidelines.

Group projects

  • Clinical effectiveness and impact of pneumococcal conjugate (CNV13) and/or polysaccharide (VNP23) vaccination in adults with different risk conditions: population-based cohort study after the introduction of universal childhood vaccination with CNV13. (2024 DI 00073). Agency for the Management of Univ and Research Grants. 2024-2027. PI: Verónica Torras Vives.
  • Impact of the introduction of PCV13 in the universal childhood vaccination schedule, on the incidence and mortality of pneumonia from all causes in adults >50 years of age in Catalonia. Primary Care Foundation (FAP) - CAMFIC; Jordi Gol i Gurina Primary Care Research Institute (IDIAPJGol); Autonomous University of Barcelona (UAB). 2022-2027. PI: Verónica Torras Vives.
  • Impact of the introduction of Pn13 in the universal childhood vaccination schedule, on the incidence and mortality of pneumonia from all causes in adults >50 years of age in Catalonia. Jordi Gol i Gurina Primary Care Research Institute (IDIAPJGol). PI: Verónica Torras Vives.
  • Clinical effectiveness and impact of pneumococcal conjugate (PCV13) and/or polysaccharide (NPV23) vaccination in adults with different risk conditions: population-based cohort study after the introduction of universal childhood vaccination with PCV13. (PI20/01223). Carlos III Health Institute. 2020-2025. PI: Ángel Vila Corcoles.

Group publications

  • Jiménez NG, Satué Gracia E, Contel JC, Gallisà JB, Amblàs Novellas J. Feasibility, Reliability, and Validity of the VIG-Express Questionnaire as an Instrument for Rapid Multidimensional Geriatric Assessment: A Multicenter Study. Aten Primaria. 2025; 57(4):PMID:39454430.
  • Forcadell Peris MJ, Vila Córcoles À, de Diego Cabanes C, Torras Vives V, Ochoa Gondar O, Satué Gracia EM. Evaluating Sex Differences in Pneumococcal Disease Burden and Vaccination Effectiveness in Adults: A Population-Based Study. J Infect Dis. 2025; PMID:39676526.
  • Clua Espuny JL, Gentille Lorente D, Hernández Pinilla A, Satué Gracia EM, Pallejà Millán M, Martín Luján FM et al. MVP Risk score and new atrial fibrillation diagnosis: Prospective cohort PREFATE study. Aten Primaria. 2025; 57(1):103071-103071. PMID:39265318.
  • Agràs Guàrdia M, Martínez Torres S, Satué E, Granado Font E, Pallejà Millán M, Patricio D et al. Experiences of smoking and tobacco use during pregnancy: A qualitative study protocol. PLoS One. 2024; 19(8):PMID:39121101.
  • Pareja Rossell C, Rabanal Tornero M, Oliva G, Gens Barberà M, Hospital Guardiola I, Hernandez Vidal N et al. Patient safety reporting and learning system of Catalonia (SNiSP Cat): a health policy initiative to enhance culture, leadership and professional engagement. BMJ Open Qual. 2024; 13(3):1-11. PMID:39117393.
  • Gens Barberà M, Astier Peña MP, Hernández Vidal N, Hospital Guardiola I, Bejarano Romero F, Oya Girona EM et al. Patient Safety Incidents in Primary Care: Comparing APEAS-2007 (Spanish Patient Safety Adverse Events Study in Primary Care) with Data from a Health Area in Catalonia (Spain) in 2019. Healthcare (Basel). 2024; 12(11):PMID:38891161.
  • Hernández Pinilla A, Clua Espuny JL, Satué Gracia EM, Pallejà Millán M, Martín Luján FM, PREFA TE S. Protocol for a multicentre and prospective follow-up cohort study of early detection of atrial fibrillation, silent stroke and cognitive impairment in high-risk primary care patients: the PREFA-TE study. BMJ Open. 2024;14(2): PMID:38373864.
Anar a l'inici